Skip to main content
SpringerLink
Log in

Low Molecular Weight Cytokine Inducers

  • Chapter
Strategies for Immunointerventions in Dermatology

  • 83 Accesses

Abstract

Skin is in many ways a unique immunological organ acting as a primary interface between the host and the outside environment. It provides an important barrier function against intruding antigens and an efficient defense system against infections. Skin with an impaired barrier function, as seen, for example, in atopic dermatitis, is prone to chronic inflammation and infection [19].

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Baschang G (1989) Muramylpeptides and lipopeptides: studies towards immunostimulants. Tetrahedron 45:6331–6360.

    Article  CAS  Google Scholar 

  2. Bourrie B, Bouaboula M, Benoit JM, Derocq JM, Esclangon M, Le Fur G, Casellas P (1995) Enhancement of endotoxin-induced interleukin-10 production by SR 31747A, a sigma ligand. Eur J Immunol 25:2882–2887.

    Article  PubMed  CAS  Google Scholar 

  3. Bourrie B, Benoit JM, Derocq JM, Esclangon M, Thomas C, Le Fur G, Casellas P (1996) A sigma ligand, SR 31747A, potently modulates Staphylococcal enterotoxin B-induced cytokine production in mice. Immunology 88:389–393.

    Article  PubMed  CAS  Google Scholar 

  4. Carr DJ, De Costa BR, Radesca L, Blalock JE (1991) Functional assessment and partial characterization of [3H] (+)-pentazocine binding sites on cells of the immune system. J Neuroimmu- nol 35:153–165.

    CAS  Google Scholar 

  5. Casellas P, BourriP B, Canat X, Carayon P, Buisson I, Paul R. BreliPre JC, Le Fur G (1994) Immunopharmacological profile of SR 31747: in vitro and in vivo studies on humoral and cellular responses. J Neuroimmunol 52:193–203.

    Article  PubMed  CAS  Google Scholar 

  6. Derocq JM, BourriP B, SPgui M, Le Flur G, Casellas P (1995) In vivo inhibition of endotoxin- induced pro-inflammatory cytokines production by the sigma ligand SR 31747. J Pharmacol Exp Ther 272:224–230.

    PubMed  CAS  Google Scholar 

  7. Engelhardt R, Foster C, Golenbock D, Hildebrandt J, Landmann R, Mayer P, Stern A, Stütz P (1995) SDZ MRL 953, a lipid A analog as selective cytokine inducer. In: Levin C, Alving R, Munford R, Redl H (eds) Bacterial endotoxins. Lipopolysaccharides from genes to therapy. Wiley-Liss, New York, pp 549–565 (Progress in clinical and biological research, vol 392)

    Google Scholar 

  8. FaheyTJIII, TurbevilleT, McIntyre K (1995) Differential TNF expression by wound fibroblasts compared to normal fibroblasts in response to LPS. J Surg Res 58:759–764.

    Article  PubMed  Google Scholar 

  9. Grewe M, Walther S, Gyufko K, Czech W, SchöpfE, Krutmann] (1995) Analysis of the cytokine pattern in situ in inhalant allergen patch test reactions of atopic dermatitis patients. J Invest Dermatol 105:407–410.

    Article  PubMed  CAS  Google Scholar 

  10. Hiraoka A, Masaoka T, Satoh T, Öta K, Oyama A, Horiuchi A, Hasegawa LL Takegawa Y, Hata K (1988) Hematological response to the new synthetic muramyl dipeptide derivative muroc- tasin after chemotherapy in patients with malignant lymphoma. Arzneimittelforschung/Drug Res 38:1499–1501.

    CAS  Google Scholar 

  11. Jeannin JF, Onier N, Lagadec P, von JeneyN, Stütz P, Liehl E (1991) Antitumor effect of synthetic derivatives of lipid A in an experimental model of colon cancer in the rat. Gastroenterology 101:726–733.

    PubMed  CAS  Google Scholar 

  12. Kapp A (1993) The roles of cytokines in the psoriatic inflammation. J Dermatol Sei 5:133–142.

    Article  CAS  Google Scholar 

  13. Kiani A, Tschiersch A, Gaboriau E, Seiz A, Knopf HP, Stütz P, Färber L, Haus U, Galanos C, Mertelsmann R, Engelhardt R (1996) Downregulation of the proinflammatory cytokine response to endotoxin by pretreatment with the non-toxic lipid A analog SDZ MRL 953 in cancer patients (submitted).

    Google Scholar 

  14. Kleinerman ES, Murray JL, Snyder JS, Cunningham JE, Fidler IJ (1989) Activation of tumori- cidal properties in monocytes from cancer patients following intravenous administration of liposomes containing muramyl tripeptide phosphatidyl ethanolamine Cancer Res 49: 4665–4670.

    CAS  Google Scholar 

  15. Kondo S, Sauder DN (1995) Epidermal cytokines in allergic contact dermatitis. J Am Acad Dermatol 33:786–800.

    Article  PubMed  CAS  Google Scholar 

  16. Lam C, Schütze E, Liehl E, Stütz P (1991a) Effect of SDZ MRL 953 on the survival of mice with advanced sepsis that cannot be cured by antibiotics alone. Antimicrob Agents Chemother 35:506–511.

    PubMed  CAS  Google Scholar 

  17. Lam C, Schütze E, Hildebrandt J, Aschauer H, Liehl E, Macher 1, Stütz P (1991 b) SDZ MRL 953, a novel immunostimulatory monosaccharidic lipid A analog with an improved therapeutic window in experimental sepsis. Antimicrob Agents Chemother 35:500–506.

    PubMed  CAS  Google Scholar 

  18. Lederer E (1988) Natural and synthetic immunomodulators derived from the mycobacterial cell wall. In: Bizzini B, Bonmassar E (eds) Advances in immunomodulation. Pythagora, Roma-Milan, pp 9–36.

    Google Scholar 

  19. Leyden JJ, MarpleRR, Kligman AM (1974) Staphylococcus aureus in the lesions of atopic dermatitis. Br J Dermatol 90:525–530.

    Article  PubMed  CAS  Google Scholar 

  20. Liebes L, Walsh CM, Chachoua A, Oratz R, Richards D, Höchster H, Peace D, Marino D, Alba S, Le Sher D, Blum RH, Vilcek J (1992) Modulation of monocyte functions by muramyl tripeptide phosphatidylethanolamine in a phase II study in patients with metastatic melanoma. J Natl Cancer Inst 84:694–699.

    Article  PubMed  CAS  Google Scholar 

  21. Liehl E, Lam C, Mayer P, Schütze E, Bahr G, Grobmüller, Stütz P, Hildebrandt J (1993) SDZ MRL 953, a new cytokine inducing agent and stimulant for non-specific immunity. In: Levin J, Alvin R, Munford R, Stütz P (eds) Endotoxin research series, vol 2. Bacterial endotoxin: recognition and effector mechanisms. International Congress Series 1020. Excerpta Medica. Amsterdam, pp 399–413

    Google Scholar 

  22. Luger T, Schwarz T (eds) (1994) Epidermal growth factors and cytokines. Dekker, New York.

    Google Scholar 

  23. Mateo RB, Reichner JS, Albina IF (1994) Interleukin 6 activity in wounds. Am J Physiol 266:R1840–1844

    Google Scholar 

  24. Metzger DW, Raeder R, Van Cleave VH, Boyle MD (1995) Protection of mice from group A streptococcal skin infection by interleukin 12.J Infect Dis 171:1643–1645

    Article  PubMed  CAS  Google Scholar 

  25. Mussi A, Bonifati C, Carducci M, Viola M, Tomaselli R, Sacerdoti G, Fazio M, Ameglio F (1994) IL-10 levels are decreased in psoriatic lesional skin as compared to the psoriatic lesion-free and normal skin suction blister fluids. J Biol Regul Homeost Agents 8:117–120

    PubMed  CAS  Google Scholar 

  26. Mustoe TA, Pierce GF, Morishima C, Deuel TF (1991) Growth factor-induced acceleration of tissue repair through direct and inductive activities in a rabbit dermal ulcer model. J Clin Invest 87:694–703.

    Article  PubMed  CAS  Google Scholar 

  27. Nagao S, Kawabata Y, Kitano M, Suzuki K, Nishikawa T, Takada H (1995) Modifications of delayed-type hypersensitivy reactions by muramyldipeptide in guinea pigs. FEMS Immunol Med Microbiol 11:231–245.

    Article  PubMed  CAS  Google Scholar 

  28. Nickoloff BJ, Turka LA, Mitra RS, Nestle FO (1995) Direct and indirect control of T-cell activation by keratinocytes. J Invest Dermatol 105:25S–29S.

    Article  PubMed  CAS  Google Scholar 

  29. Ohta Y, Nishiyama S, Nishioka K (1994) In situ expression of interleukin-6 in psoriatic epidermis during treatment. J Dermatol 21:301–307.

    PubMed  CAS  Google Scholar 

  30. Ono I, Gunji H, Zhang JZ, Mauyama K, Kaneko F (1995a) A study of cytokines in burn blister fluid related to wound healing. Burns 21: 352–355.

    Article  PubMed  CAS  Google Scholar 

  31. Ono I, Gunji H, Zhang JZ, Mauyama K, Kaneko F (1995b) Studies on cytokines related to wound healing in donor site wound fluid. J Dermatol Sei 10: 241–245.

    Article  CAS  Google Scholar 

  32. Otani T, Une T, Osada Y (1988) Stimulation of non-specific resistance to infection by muroc- tasin. Arzneimittelforschung/Drug Res 38:969–976.

    CAS  Google Scholar 

  33. Paul R, Lavastre S, Floutard D, Floutard R, Canat X, Casellas P (1994) Allosteric modulation of peripheral sigma binding sites by a new selective ligand, SR 31747. J Neuroimmunol 52: 183–192.

    Article  PubMed  CAS  Google Scholar 

  34. Prens EP, van Joost T, Hegmans JP, tHooft-Benne K, Ysselmuiden OE (1995) Effects of cyclosporine on cytokines and cytokine receptors in psoriasis. J Am Acad Dermatol 33: 947–953.

    Article  PubMed  CAS  Google Scholar 

  35. Rakhmilevich AL, Rakhimova MS, Andronova TM, Bovin MV (1989) In vitro immunostimu- lated effect of muramyldipeptide, glucosaminyl-muramyldipeptide and their synthetic derivatives. Antibiot Khimioter 34:586–589.

    PubMed  CAS  Google Scholar 

  36. Schoenwald RD, Barfknecht CF, Shirolkar-S, Xia E (1995) The effects of sigma ligands on protein release from lacrimal acinar cells: a potential agonist/antagonist assay Life Sei 56: 1275–1285.

    CAS  Google Scholar 

  37. Schroeder JM (1995) Cytokine networks in the skin. J Invest Dermatol 105:20S–24S.

    Article  CAS  Google Scholar 

  38. Stoof T, Boorsma D, Nickoloff B (1994) Keratinocytes and Immunological Cytokines. In: Leigh I, Lane B, Watt F (eds) The keratinocyte handbook. Cambridge University Press, Cambridge, pp 365–399.

    Google Scholar 

  39. Stütz P, Bahr G, Hildebrandt J, Lam C, Liehl E, Macher I, Mayer P, Schütze E (1995) Antimicrobial properties and cytokine release by an LPS-mimetic lipid A analog. In: Tellado JM, Forse RA, Solomkin JS (eds) Modulation of the inflammatory response in severe sepsis. Karger, Basel, pp 167–178 (Progress in surgery, vol 20)

    Google Scholar 

  40. Su TP, London ED, Jaffe JH (1988) Steroid binding at sigma receptors suggests a link between endocrine, nervous and immune systems. Science 240:219–221.

    Article  PubMed  CAS  Google Scholar 

  41. Takashima A (1995) UVB-dependent modulation of epidermal cytokine network: roles in UVB-induced depletion of Langerhans cells and dendritic epidermal T cells. J Dermatol 22:876–887.

    PubMed  CAS  Google Scholar 

  42. Tsubura E, Nomura T, Niitani H, Osamura S, Okawa T, Tanaka M, Ota K, Nishikawa H, Masaoka T, Ogura T, Kozuru M, Hara N, Hara K, Ichimaru M Taktsuki K (1988) Restorative activity of muroctasin on leukopenia associated with anticancer treatment. Arzneimittelforschung/Drug Res 38:1070–1074.

    CAS  Google Scholar 

  43. World Patent WO 96/01645 (1996) The use of muramyl peptide compounds (GMDP).

    Google Scholar 

  44. Yamaguchi F, Akasaki M, Tsukada W (1988) Induction of colony-stimulating factor and stimulation of stem cell proliferation by injection of muroctasin. Arzneimittelforschung/Drug Res 38:980–983.

    CAS  Google Scholar 

  45. Zunic M, Bahr G, Dukor P, Lam C (1996) In vitro anti-inflammatory active of a synthetic derivative of muramyl dipeptide: downregulation of pro-inflammatory cytokines and iNOS. Skin Pharmacol 9:168.

    Google Scholar 

Download references

Authors
  1. P. Stütz
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. E. Liehl
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Dermatology, University Hospital Zurich, Gloriastrasse 31, CH-8091, Zurich, Switzerland

    Günter Burg M.D. (Chairman) (Chairman)

  2. Department of Dermatology, University Hospital Zurich, Gloriastrasse 31, CH-8091, Zurich, Switzerland

    Reinhard G. Dummer M.D.

Rights and permissions

Reprints and permissions

Copyright information

© 1997 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Stütz, P., Liehl, E. (1997). Low Molecular Weight Cytokine Inducers. In: Burg, G., Dummer, R.G. (eds) Strategies for Immunointerventions in Dermatology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-60752-3_18

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-60752-3_18

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-64539-6

  • Online ISBN: 978-3-642-60752-3

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation